Over 50% of the world’s most popular drugs are sourced directly or indirectly from natural sources. Pioneering research in marine based drug discovery began with Roche Research Institute of Marine Pharmacology during the mid 1970s. Tethya crypta a marine sponge was the first organism to be commercialized to produce drugs against HIV & Herpes. A small number of marine organisms primarily constituting of algae and other invertebrates have already been researched for commercial value in pharmaceuticals.
Marine organisms have been found to be capable of providing solutions for major human diseases such as cancer, Alzheimer’s, herpes and many others. With the rate of success and growth in this area, it is expected that the market for marine-derived pharmaceutical products will increase in the coming months rapidly and double by 2018. Several of the marine organisms used for extracting drugs are deep sea bacteria, sponges, mollusks, fungi, and tunicates. Even with such strong R&D activities in marine organisms, it is believed that no more than 10% of organisms have been researched as potential candidates.
A large number of marine organisms still remain viable avenues for research.
Primary research and market analysis shows sponges and marine animals to be the largest source of pharmaceutical products. In terms of geography, North America is expected to be the largest market for marine based pharmaceuticals. The history of marine-derived products began from cod-liver oil, shark oil, and calcium supplements. Marine biotechnology has developed over the years propelled by the unmet needs for new and innovative pharmaceutical products. Potential pipeline drugs being developed are anti-viral, anti-cancer drugs from byrozoans, anti-microbial, and anti-inflammatory.
Increasing marine biodiversity preservation and research programs throughout the world are a definite sign that the world is getting ready for a new variety of pharmaceutical compounds that would be fighting a broad spectrum of diseases. With an estimated 70% organisms to be investigated, pharmaceutical companies hope to find a cure for high-risk and fatal diseases in the coming years. Marine organisms are expected to be viable for production of drug compounds, biomaterials, nutritional supplements, and several types of algae are being used for the production of alcohol as an energy source.
This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments